Pituitary Macroadenoma in a Girl with Male Karyotype: A Rare Case Study
Keywords:
Disorder of sex development (DSD), primary amenorrhea, pituitary macroadenomaAbstract
Macroadenoma is a tumor that typically develops in the epithelial cells of the pituitary gland. Patients suffering from the condition are often asymptomatic with complaints that are caused by hormonal imbalance. Therefore, chromosome analysis needs to be done to females aged >16 years presenting with amenorrhea. Karyotype 46,XY is a disorder of sex development (DSD) that is caused by the complex process of gene interactions, androgen synthesis, and hormone regulation. The patient initially came to the hospital for a scheduled transsphenoidal surgery due to pituitary macroadenoma, and later complained of primary amenorrhea and atypical external genital. Furthermore, physical examination of genitalia revealed mild clitoromegaly without obvious introitus vagina. Laboratory testing showed elevated prolactin and testosterone level, while ultrasonography imaging revealed the absence of the uterus and ovaries. The brain magnetic resonance imaging (MRI) demonstrated a pituitary adenoma, and cytogenetic analysis showed 46,XY karyotype. Subsequently, hyperprolactinemia, imaging, and histopathology examination were used to confirm pituitary macroadenoma in the patient. It was assumed that the undermasculinized genitalia was caused by hormonal disorders including the deficiency of androgen action or 5-alpha-reductase enzyme. 46,XY DSD has many different symptoms, hence, clinicians need to be aware of potential multifactorial aetiologies. Imaging of internal genitalia, hormonal and chromosomal analysis should be carried out to assess patients with unknown causes of the disorder. Molecular analysis needs to be carried to exclude the possible gene mutation.References
Hughes IA, Houk C, Ahmed SF, Lee PA, Group LEC. Consensus statement on management of intersex disorders. Arch Dis Child. 2006;91:554-63.
Nordenström A. Puberty in individuals with a disorder of sex development. Current Opinion in Endocrine and Metabolic Research. 2020;14:42-51.
Cools M, Drop SL, Wolffenbuttel KP, Oosterhuis JW, Looijenga LH. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev. 2006;27(5):468-84.
Wisniewski AB, Mazur T. 46, XY DSD with female or ambiguous external genitalia at birth due to androgen insensitivity syndrome, 5α-reductase-2 deficiency, or 17β-hydroxysteroid dehydrogenase deficiency: A review of quality of life outcomes. Int J Pediatr Endocrinol. 2009;2009:1-7.
Mendonca BB, Domenice S, Arnhold IJ, Costa EM. 46,XY disorders of sex development (DSD). Clin Endocrinol (Oxf). 2009;70(2):173-87.
Kadhim MM, Aboud MJ. Disorders of sex development: Molecular versus clinical and cytogenetic studies and their correlation with diagnostic outcome and sex of rearing in a local community. JMSCR. 2014;2(7):1626-46.
Khanna K, Sharma S, Gupta DK. A clinical approach to diagnosis of ambiguous genitalia. J Indian Assoc Pediatr Surg. 2019;24(3):162-9.
Brain CE, Creighton SM, Mushtaq I, et al. Holistic management of DSD. Best Pract Res Clin Endocrinol Metab. 2010;24(2):335-54.
Listyasari NA, Santosa A, Juniarto AZ, Faradz SMH. Multidisciplinary management of disorders of sex development in Indonesia, a prototype in developing country. Journal of Biomedicine and Translational Research. 2017;3(1).
R K, I M, M E, M M, A E. Genetic and clinical study of disorder of sex development among children and adolecents. Life Science Journal. 2020;17(6).
öcal G. Current concepts in disorders of sex development. J Clin Res Ped Endo 2011;3(3):105-14.
Wisniewski AB. Gender development in 46,XY DSD: Influences of chromosomes, hormones, and interactions with parents and healthcare professionals. Scientifica (Cairo). 2012;2012:834967.
Wisniewski AB, Batista RL, Costa EMF, et al. Management of 46,XY differences/disorders of sex development (DSD) throughout life. Endocr Rev. 2019;40(6):1547-72.
Jung EJ, Im DH, Park YH, et al. Female with 46, XY karyotype. Obstet Gynecol Sci. 2017;60(4):378-82.
Ahmed SF, Bashamboo A, Lucas-Herald A, McElreavey K. Understanding the genetic aetiology in patients with XY DSD. Br Med Bull. 2013;106:67-89.
Homa L, Thomas S, Sanfilippo J. Primary amenorrhea with transverse vaginal septum and scant hematocolpos: A case report. Open J Pediatrics. 2012;02(01):87-91.
Rutkowski MJ, Alward RM, Chen R, et al. Atypical pituitary adenoma: a clinicopathologic case series. J Neurosurg. 2018;128(4):1058-65.
Jang MK, Oh EG, Lee H, Kim EH, Kim S. Postoperative symptoms and quality of life in pituitary macroadenomas patients. Journal of Neuroscience Nursing. 2020;52(1):30-6.
Maleki N, Kalantar Hormozi M, Iranparvar Alamdari M, Tavosi Z. 5-alpha-reductase 2 deficiency in a woman with primary amenorrhea. Case Rep Endocrinol. 2013;2013:631060.
Berra M, Williams EL, Muroni B, et al. Recognition of 5alpha-reductase-2 deficiency in an adult female 46XY DSD clinic. Eur J Endocrinol. 2011;164(6):1019-25.
Campbell IM, Yuan B, Robberecht C, et al. Parental somatic mosaicism is underrecognized and influences recurrence risk of genomic disorders. Am J Hum Genet. 2014;95(2):173-82.
Parisi MA, Ramsdell LA, Burns MW, et al. A Gender Assesstment Team: experience with 250 patients over a period of 25 years. Genet Med 2007;9(6):348-57.
Moshiri M, Chapman T, Fechner PY, et al. Evaluation and management of disorder of sex development : Multidisciplinary approach to complecx diagnosis. . radiographicsrsnaorg. 2012;32(6):1599-618.
Hummadi AA, Yahya AO, Al-Qahtani AM. Late diagnosis of 5-alpha-reductase type 2 deficiency in an adolescent girl with primary amenorrhoea. Sultan Qaboos Univ Med J. 2017;17(2):e218-e20.
Lanciotti L, Cofini M, Leonardi A, Bertozzi M, Penta L, Esposito S. Different clinical presentations and management in complete androgen insensitivity syndrome (CAIS). Int J Environ Res Public Health. 2019;16(7).
Tortosa F, Webb SM. Novel aspects in histopathology of the pituitary gland. Endocrinología, Diabetes y Nutrición (English ed). 2017;64(3):152-61.
Vilar L, Vilar Clarice F, Lyra R, Freitas Maria da C. Pitfalls in the diagnostic evaluation of hyperprolactinemia. Neuroendocrinology. 2019;109(1):7-19.
Qari FA, AbuDaood EA, Nasser TA. Diabetes insipidus following neurosurgery at a university hospital in Western Saudi Arabia. Saudi Med J. 2016;37(2):156-60.
de Vries F, Lobatto DJ, Verstegen MJT, van Furth WR, Pereira AM, Biermasz NR. Postoperative diabetes insipidus: how to define and grade this complication? Pituitary. 2021;24(2):284-91.
Looijenga LH, Hersmus R, Oosterhuis JW, Cools M, Drop SL, Wolffenbuttel KP. Tumor risk in disorders of sex development (DSD). Best Pract Res Clin Endocrinol Metab. 2007;21(3):480-95.
Downloads
Published
How to Cite
Issue
Section
License
CopyrightThe authors who publish this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
